- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Buprenorphine – November 2018
Buprenorphine: Injection 8 mg in 0.16 mL pre-filled syringe, Injection 16 mg in 0.32 mL pre-filled s
Last updated
15 March 2019